Inventor · disambiguated record
Shuang Liu
Also filed as: LIU SHUANG · LIU SHUANG PETER
75 granted patents·23 pending applications·1,026 citations·filing 1994–2025
99Inventor score
Files withBRISTOL MYERS SQUIBB PHARMA CO18ZENITH EPIGENETICS LTD12LIU SHUANG10BRISTOL MYERS SQUIBB CO7ALBANY MOLECULAR RES INC5
Top patents by PatentIndex Score
98 records- 0195US9604960B2Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereofALBANY MOLECULAR RES INC·Filed 2015·Granted Mar 28, 2017·28 cites·45 claims
- 0295US6537520B1Pharmaceuticals for the imaging of angiogenic disordersBRISTOL MYERS SQUIBB PHARMA CO·Filed 2000·Granted Mar 25, 2003·91 cites·37 claims
- 0394US9861637B2Heterocyclic compounds as bromodomain inhibitorsZENITH EPIGENETICS LTD·Filed 2017·Granted Jan 9, 2018·20 cites·19 claims
- 0494US9662311B2Substituted bicyclic compounds as bromodomain inhibitorsZENITH EPIGENETICS LTD·Filed 2014·Granted May 30, 2017·25 cites·6 claims
- 0594US9271978B2Heterocyclic compounds as bromodomain inhibitorsLIU SHUANG·Filed 2013·Granted Mar 1, 2016·30 cites·13 claims
- 0694US7541357B2Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotoninAMR TECHNOLOGY INC·Filed 2005·Granted Jun 2, 2009·24 cites·37 claims
- 0793US9663520B2Bicyclic bromodomain inhibitorsZENITH EPIGENETICS CORP·Filed 2015·Granted May 30, 2017·16 cites·25 claims
- 0893US9278940B2Cyclic amines as bromodomain inhibitorsFAIRFAX DAVID JOHN·Filed 2015·Granted Mar 8, 2016·25 cites·31 claims
- 0993US6800273B2Pharmaceuticals for the imaging of angiogenic disordersBRISTOL MYERS SQUIBB PHARMA CO·Filed 2003·Granted Oct 5, 2004·46 cites·25 claims
- 1092US9636328B2Substituted bicyclic compounds as bromodomain inhibitorsZENITH EPIGENETICS CORP·Filed 2014·Granted May 2, 2017·19 cites·6 claims
- 1192US9598367B2Heterocyclic compounds as bromodomain inhibitorsZENITH EPIGENETICS CORP·Filed 2016·Granted Mar 21, 2017·15 cites·4 claims
- 1292US6776977B2Polypodal chelants for metallopharmaceuticalsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2001·Granted Aug 17, 2004·36 cites·3 claims
- 1391US9650376B2Imidazo(4,5-B) pyridin-2-yl amides as KV7 channel activatorsKNOPP BIOSCIENCES LLC·Filed 2014·Granted May 16, 2017·8 cites·23 claims
- 1491US9073878B2Cyclic amines as bromodomain inhibitorsFAIRFAX DAVID JOHN·Filed 2013·Granted Jul 7, 2015·20 cites·19 claims
- 1591US8575114B2SGLT-2 inhibitors, methods of making them, and uses thereofLIU SHUANG·Filed 2011·Granted Nov 5, 2013·24 cites·7 claims
- 1690USD1086429SFolding fanLIU SHUANG·Filed 2024·Granted Jul 29, 2025·11 cites·1 claims
- 1790US7067540B2Substituted pyridinonesPHARMACIA CORP·Filed 2003·Granted Jun 27, 2006·44 cites·45 claims
- 1890US6713042B2Ascorbic acid analogs for metalloradiopharmaceuticalsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2002·Granted Mar 30, 2004·35 cites·45 claims
- 1990US6022523ARadiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disordersDU PONT PHARM CO·Filed 1997·Granted Feb 8, 2000·46 cites·1 claims
- 2089US10363257B2Bicyclic bromodomain inhibitorsZENITH EPIGENETICS LTD·Filed 2018·Granted Jul 30, 2019·8 cites·48 claims
- 2189US8236796B2Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotoninMOLINO BRUCE F·Filed 2009·Granted Aug 7, 2012·10 cites·46 claims
- 2289US8227486B2Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotoninMOLINO BRUCE F·Filed 2008·Granted Jul 24, 2012·10 cites·19 claims
- 2389US5750088AStable hydrazones linked to a peptide moiety as reagents for the preparation of radiopharmaceuticalsDU PONT MERCK PHARMA·Filed 1995·Granted May 12, 1998·49 cites·7 claims
- 2488US7956050B2Aryl- and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotoninALBANY MOLECULAR RES INC·Filed 2006·Granted Jun 7, 2011·13 cites·28 claims
- 2587US8445494B2Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amineQIU JUN·Filed 2009·Granted May 21, 2013·11 cites·1 claims
- 2686US10010556B2Bicyclic bromodomain inhibitorsZENITH EPIGENETICS LTD·Filed 2017·Granted Jul 3, 2018·4 cites·54 claims
- 2785US6869590B2Labeled macrophage scavenger receptor antagonists for imaging atherosclerosis and vulnerable plaqueBRISTOL MYERS SQUIBB PHARMA CO·Filed 2002·Granted Mar 22, 2005·19 cites·49 claims
- 2884US8420811B2Tetrahydroisoquinolines and intermediates thereforLOBBEN PAUL·Filed 2009·Granted Apr 16, 2013·11 cites·2 claims
- 2984US6974567B2Labeled macrophage scavenger receptor antagonists for imaging atherosclerosis and vulnerable plaqueBRISTOL MYERS SQUIBB PHARMA CO·Filed 2003·Granted Dec 13, 2005·14 cites·63 claims
- 3084US6825204B2N-substituted 3-hydroxy-4-pyridinones and pharmaceuticals containing thereofBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Nov 30, 2004·19 cites·15 claims
- 3184US6565828B2Macrocyclic chelants for metallopharmaceuticalsBRISTOL MYERS SQUIBB CO·Filed 2001·Granted May 20, 2003·24 cites·43 claims
- 3284US6517814B2Macrocyclic chelants useful for metallopharmaceuticalsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2001·Granted Feb 11, 2003·19 cites·43 claims
- 3382US9156812B2Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amineBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Oct 13, 2015·3 cites·7 claims
- 3482US6932960B2N-substituted 3-hydroxy-4-pyridinones and pharmaceuticals containing thereofBRISTOL MYERS SQUIBB PHARMA CO·Filed 2004·Granted Aug 23, 2005·15 cites·6 claims
- 3581US9499531B2Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotoninALBANY MOLECULAR RES INC·Filed 2015·Granted Nov 22, 2016·2 cites·6 claims
- 3681US7629363B2Diaryl substituted pyridinonesPFIZER·Filed 2005·Granted Dec 8, 2009·5 cites·31 claims
- 3781US6916460B2Macrocyclic chelants for metallopharmaceuticalsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2003·Granted Jul 12, 2005·10 cites·24 claims
- 3881US6685914B1Macrocyclic chelants for metallopharmaceuticalsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2000·Granted Feb 3, 2004·10 cites·34 claims
- 3980US10226451B2Substituted bicyclic compounds as bromodomain inhibitorsZENITH EPIGENETICS LTD·Filed 2017·Granted Mar 12, 2019·2 cites·5 claims
- 4080US6534038B2Ternary ligand complexes useful as radiopharmaceuticalsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2001·Granted Mar 18, 2003·12 cites·47 claims
- 4180US6416733B1Radiopharmaceuticals for imaging infection and inflammationBRISTOL MYERS SQUIBB PHARMA CO·Filed 1997·Granted Jul 9, 2002·56 cites·11 claims
- 4278US7052673B2Pharmaceuticals for the imaging of angiogenic disordersBRISTOL MYERS SQUIBB PHARMA CO·Filed 2003·Granted May 30, 2006·8 cites·22 claims
- 4376US10166215B2Substituted bicyclic compounds as bromodomain inhibitorsZENITH EPIGENETICS LTD·Filed 2017·Granted Jan 1, 2019·1 cites·14 claims
- 4473US5744120ATernary radiopharmaceutical complexesDU PONT MERCK PHARMA·Filed 1995·Granted Apr 28, 1998·40 cites·30 claims
- 4572US11446306B2Bicyclic bromodomain inhibitorsZENITH EPIGENETICS LTD·Filed 2020·Granted Sep 20, 2022·0 cites·22 claims
- 4672US9034899B2Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereofLIU SHUANG·Filed 2010·Granted May 19, 2015·2 cites·17 claims
- 4769US8791101B2Aryl- and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotoninMOLINO BRUCE F·Filed 2010·Granted Jul 29, 2014·1 cites·34 claims
- 4868US12152266B2Method for preparing active protein peptide and prepared active protein peptide and use thereofLIU SHUANG·Filed 2023·Granted Nov 26, 2024·0 cites·9 claims
- 4966US10772892B2Bicyclic bromodomain inhibitorsZENITH EPIGENETICS LTD·Filed 2019·Granted Sep 15, 2020·0 cites·15 claims
- 5065US11026926B2Substituted bicyclic compounds as bromodomain inhibitorsZENITH EPIGENETICS LTD·Filed 2019·Granted Jun 8, 2021·0 cites·7 claims
Showing the top 50 of 98 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Shuang Liu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →